Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Yiting Bao"'
Publikováno v:
Frontiers in Cellular and Infection Microbiology, Vol 14 (2024)
A growing body of research has established a correlation between tumors and persistent chronic inflammatory infiltration. As a primary instigator of inflammation, the majority of microbiomes naturally residing within our bodies engage in a mutually b
Externí odkaz:
https://doaj.org/article/d5e895931ed54d83a3e5153890c00844
Publikováno v:
World Journal of Surgical Oncology, Vol 22, Iss 1, Pp 1-14 (2024)
Abstract Background Epithelial ovarian cancer (EOC) is insensitive to immunotherapy due to its poor immunogenicity; thus, suitable biomarkers need to be identified for better prognostic stratification and individualized treatment. CD47 is a novel imm
Externí odkaz:
https://doaj.org/article/42297274b2da4cdabd10f2aa5cdd46b8
Publikováno v:
Journal of Ovarian Research, Vol 16, Iss 1, Pp 1-10 (2023)
Abstract Background The risk of suffering epithelial ovarian cancer (EOC) for women increases with age evidently, while the prognosis of older EOC patients remain unclear. Against the backdrop of the accelerate aging process in China, this paper inve
Externí odkaz:
https://doaj.org/article/0e62f78c6bad4aef9655b2927a37f381
Autor:
Rongyi Wang, Hongsen Li, Lu Han, Boao Han, Yiting Bao, Hongwei Fan, Chaoyue Sun, Ruijie Qian, Liying Ma, Jiajing Zhang
Publikováno v:
Frontiers in Bioengineering and Biotechnology, Vol 12 (2024)
The mitochondria act as the main producers of reactive oxygen species (ROS) within cells. Elevated levels of ROS can activate the mitochondrial apoptotic pathway, leading to cell apoptosis. In this study, we devised a molecular prodrug named CTT2P, d
Externí odkaz:
https://doaj.org/article/9bb3896cf7574ebb99588d4707ce2879
Autor:
Xukai Luo MM, Yini Shen MM, Wu Huang MM, Yiting Bao MM, Jiahang Mo MM, Liangqing Yao MD, Lei Yuan MD
Publikováno v:
Cancer Control, Vol 30 (2023)
Among the three primary gynecological malignancies, ovarian cancer has the lowest incidence but the worst prognosis. Because of the poor prognosis of ovarian cancer patients treated with existing treatments, immunotherapy is emerging as a potentially
Externí odkaz:
https://doaj.org/article/86d51004d76d4561833b0a1a56a77b13
Publikováno v:
Journal of Education, Humanities and Social Sciences. 8:1976-1982
785 middle and high school students were polled using the Parent-Child Relationship Scale, the Adolescent Risk-taking Behavior Questionnaire, and the School Connectedness Scale in order to examine the mechanisms underlying the parent-child relationsh
Autor:
Rongyi Wang, Hongsen Li, Lu Han, Boao Han, Yiting Bao, Hongwei Fan, Chaoyue Sun, Ruijie Qian, Liying Ma, Jiajing Zhang
Publikováno v:
Frontiers in Bioengineering & Biotechnology; 2024, p1-16, 16p
Publikováno v:
Endocrine. 77:188-198
Ovarian neuroendocrine neoplasm is a rare and highly heterogeneous neoplasm. This study is aimed to describe its demographic and clinicopathological features and identify its prognostic factors.Clinical data of 399 patients diagnosed with ovarian neu
Background Primary debulking surgery (PDS) or neoadjuvant chemotherapy with interval debulking surgery (NACT-IDS) was the standard treatment for advanced ovarian cancer. Optimal cytoreduction is believed one of the most important factors for survival
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d7de03a9e5291b3e7025774c5abcba70
https://doi.org/10.21203/rs.3.rs-2463011/v1
https://doi.org/10.21203/rs.3.rs-2463011/v1